HCWB HCW Biologics Inc.
Company Analysis
Latest News
HCW Biologics to Restate Q1 2026 Financials, Overstated EPS by $0.80
HCW Biologics announced that its previously issued financial statements for the first quarter ended March 31, 2026, should no longer be relied upon due to a...
🔴 HCW Biologics is trading 7.35% down today as the cause remains unclear
HCW Biologics is trading 7.35% down at $2.71, with no confirmed company-specific catalyst identified. - The stock declined from $2.92 on August 13, 2026. - No...
🟢 HCW Biologics is trading 6% up today with no confirmed catalyst
HCW Biologics is trading 5.98% up now at $3.10, with no confirmed company-specific catalyst identified for August 14, 2026. - The move follows a 7.00% decline...
🟢 HCW Biologics is trading 19.66% up in pre-market — no confirmed catalyst identified
HCW Biologics is trading 19.66% up at $3.50 in pre-market, with no confirmed company-specific catalyst identified for August 14. - The stock fell 7.00% to...
🔴 HCW Biologics is trading 7% down in pre-market with no confirmed overnight catalyst
HCW Biologics is trading at $2.72, down 7.01%, with no confirmed company-specific announcement or earnings release identified to explain the August 14...
🟢 HCW Biologics is trading 6% up in after-hours trading — no confirmed company-specific catalyst found
HCW Biologics is trading 5.98% up in after-hours trading at $3.10 after closing at $2.92 on August 13, 2026; no confirmed company-specific announcement or...
🟢 HCW Biologics is trading 7.26% up in after-hours trading with no clear company-specific catalyst identified
HCW Biologics is trading now 7.26% up at $3.40, with no clear company-specific catalyst identified for August 11, 2026. - The latest official company release...
🟢 HCW Biologics is trading 11% up in pre-market — no clear catalyst identified
HCW Biologics is trading 11.04% up at $3.63 in pre-market, with no clearly identified company-specific announcement on August 11, 2026. - Recent coverage...
🟢 HCW Biologics is trading 6% up in pre-market after insider-backed private placement
HCW Biologics is trading 5.57% up now at $3.60 in pre-market trading, as renewed attention to a July 29 private placement involving its CEO, board chairman,...
HCW Biologics CEO Buys Shares at $2.59 — Is This a Real Confidence Signal or a Tiny Bet on a Micro-Cap Gamble?
Shares of HCW Biologics surged as much as 8.1% to $3.61 on August 7, extending a sharp rally that began after CEO Hing Wong disclosed a personal stock purchase...
🔴 HCW Biologics is trading 5.98% down today after failing to extend its recent rally
HCW Biologics is trading 5.98% down at $3.23 after failing to extend its recent rally. - The stock declined from $3.60 on August 4 to $3.43 on August 5 and...
🟢 HCW Biologics is trading 7.6% up today as it rebounds from consolidation following an insider-fueled rally
HCW Biologics is trading at $3.69 (up 7.6%) in pre-market action, appearing to rebound within an ongoing momentum cycle following a period of consolidation. •...
🔴 HCW Biologics is trading 10.8% down today on profit-taking after an insider-driven rally
HCW Biologics is trading 10.8% down at $3.21 as the stock undergoes consolidation and profit-taking following a sharp multi-session rally. • The recent surge...
🟢 HCW Biologics is trading 5.3% up today on continued insider-buying momentum
HCW Biologics is trading at $3.79 (5.3% up) in pre-market, extending a strong multi-day rally that began in late July. • Recent gains are driven by sustained...
🟢 HCW Biologics is trading 10.5% up today on continued momentum from CEO insider buying
HCW Biologics is trading 10.5% up today at $3.69 as traders continue to respond to recent insider buying by CEO Hing Wong. • The stock has rallied sharply...
🟢 HCW Biologics is trading 8.1% up today as CEO insider buying fuels continued momentum
HCW Biologics is trading 8.1% up at $3.61 as traders continue to respond to significant insider buying by CEO Hing Wong. • The move extends a sharp rally that...
🟢 HCW Biologics is trading 10.8% up today as CEO share purchase fuels continued momentum
HCW Biologics is trading at $3.70 (up 10.8%) as investors react to continued momentum following a recent insider share purchase by CEO Hing Wong. • The rally...
🟢 HCW Biologics is trading 24% up today after CEO Hing Wong discloses share purchase
HCW Biologics is trading at $3.96 (23.8% up) today after an SEC filing revealed that CEO and 10% owner Hing Wong purchased 23,210 shares at $2.59 on July 29,...
HCW Biologics CEO buys 23,210 shares, signaling confidence in TOBI platform
HCW Biologics CEO and 10% owner Hing Wong purchased 23,210 shares of company stock on July 29, 2026. The transaction was executed at a price of $2.59 per...
🟢 HCW Biologics is trading 10.1% up today, extending a rally fueled by a $1.6 million private placement
HCW Biologics is trading 10.1% up at $3.52 in pre-market, extending a sharp multi-day surge fueled by a $1.6 million private placement. • The move has sparked...